While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
I made exactly one trade Friday — and I went to Denmark to do it.
Some large-cap names are struggling to keep up with the rest of the market.
Your future self is begging you to check up on your portfolio holdings.
Price targets are never accurate and often over-hyped, but there are ways to use them to your advantage.
Let’s scan through the headlines for the stories of the week that speak to our Pro Portfolio holdings.
We locked in big gains, raised a few price targets, and extended our lead over the S&P 500 this week.
This is a much stronger labor market than those who vote on policy at the Fed’s FOMC thought they were going to be dealing with.
Let’s review the quarterly results, what the chart looks like and why I’m adding.
In a market addicted to upside surprises, ‘priced to perfection’ gets sold. Is this now a buying opportunity?
A small sale by Strategy may have rattled investor confidence, but the technical damage was already underway.